Lab
Ultra Medical Lab INC
Ultra Medical Lab INC was paid $583K by Medicaid between Dec 2020 and Aug 2022, across 21 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 40% of everything it billed.
33Billing provider infoULTRA MEDICAL LAB INC
TORRANCE, CA 90503
TORRANCE, CA 90503
33aNPI1124517784assigned 05/08/2018
33bProvider typeClinical Medical Laboratory
28Total paid$583K
24GClaims13,469
24DCodes billed21
24AFirst – last monthDec 2020 – Aug 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#222 of 561
Median peer was paid$222K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 277 | $5K | |
| 2021 | 7,388 | $265K | |
| 2022 | 5,804 | $312K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 40% | 1,443 | 1,089 | $233K |
| 87631 | 8.3% | 900 | 845 | $48K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 6.7% | 481 | 476 | $39K |
| 87150 | 6.2% | 392 | 365 | $36K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.1% | 742 | 738 | $30K |
| 87481 | 4.5% | 657 | 638 | $26K | |
| 87529 | 4.0% | 734 | 730 | $24K | |
| 87634 | 3.8% | 756 | 752 | $22K | |
| 87652 | 2.6% | 660 | 640 | $15K | |
| 87640 | 2.2% | 763 | 751 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 331 | 329 | $12K |
| 87486 | 2.1% | 804 | 748 | $12K |
9 more codes
| 87581 | 2.1% | 805 | $12K | |
| 87541 | 2.1% | 803 | $12K | |
| 87498 | 2.0% | 740 | $12K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 733 | $11K |
| 87500 | 2.0% | 735 | $11K | |
| 87641 | 1.9% | 635 | $11K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 119 | $3K |
| 80299 | <1% | 218 | $253.68 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 18 | $49.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWANG, JENNIFER (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Asian American Senior Citizens Service Center, INC. | Santa Ana, CA | $174K |
| Montefiore Medical Center | Bronx, NY | $93K |
| Jennifer H Wang DPM PC | Austin, TX | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.